Pascal Deschatelets - Jun 24, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Scientific Officer
Signature
/s/ David Watson, attorney-in-fact for Pascal Deschatelets
Stock symbol
APLS
Transactions as of
Jun 24, 2021
Transactions value $
-$393,375
Form type
4
Date filed
6/25/2021, 09:48 PM
Previous filing
May 25, 2021
Next filing
Jan 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $16.7K +6.25K +0.72% $2.67* 876K Jun 24, 2021 Direct F1
transaction APLS Common Stock Sale -$410K -6.25K -0.71% $65.61 870K Jun 24, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -6.25K -1.67% $0.00 369K Jun 24, 2021 Common Stock 6.25K $2.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise from 10B5-1 trading plan.
F2 This stock option was granted on 12/5/2013 and is fully vested.